Company / Working Capital per Share
KalVista Pharmaceuticals, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$4.62
FY2025
5-year range
$4.09 / $14.26
FY2021-FY2025
Trend
+13.1%
vs FY2024
Sector context
#114 of 210
Health Care
What the data says
At $4.62, KalVista Pharmaceuticals, Inc.'s working capital per share ranks #114 of 210 in the Health Care sector. Working Capital per Share returned to growth in FY2025 after 3 years of decline, reaching $4.62.
Based on SEC 10-K filings.
4.62 in FY2025 with a 5-year CAGR of -0.3%.
Improved from $4.28 to $4.62 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -14.7%
- 5-Year CAGR
- -0.3%
- 10-Year CAGR
- -
Sector benchmark
#114 of 210 in Health CareTop 54% of 210This company $4.62 Sector average $118.60
▼
-96.1% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 13.1% year-over-year.
- Ranks #114 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2021.
- Lowest working capital per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -3.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.62 | +13.1% |
| FY2024 | $4.09 | -4.4% |
| FY2023 | $4.28 | -42.6% |
| FY2022 | $7.46 | -47.7% |
| FY2021 | $14.26 | +204.3% |
| FY2020 | $4.69 | -48.1% |
| FY2019 | $9.03 | +142.5% |
| FY2018 | $3.72 | +23.3% |
| FY2017 | $3.02 | -34.5% |
| FY2016 | $4.61 | -97.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026